The Medical Research Council (MRC) is the UK’s dedicated public funder of biomedical and clinical research, one of seven discipline-based research councils inside UK Research and Innovation (UKRI). MRC funds most standard grants at 80% of full economic cost (fEC) through the UKRI Funding Service, and it is a separate body from Australia’s similarly-named National Health and Medical Research Council (NHMRC).
UKRI’s umbrella also includes Innovate UK and Research England. MRC’s own remit statement is that it funds “world-leading discovery and translational research to accelerate diagnosis, advance treatment and prevent human illness.”
MRC (UK) is not NHMRC (Australia)
Because the acronyms are so close, MRC is frequently confused with the Australian Research Council (ARC)‘s sister body, the National Health and Medical Research Council (NHMRC). They are entirely separate national funders in different countries with no shared governance:
- MRC is a UK body, one of UKRI’s seven research councils, funded through UK government science budget allocations and administered from Swindon.
- NHMRC (National Health and Medical Research Council) is Australia’s main health and medical research funder, a statutory agency of the Australian Government, running schemes such as the NHMRC Investigator Grant and NHMRC Ideas Grant through its own Sapphire grants-management system.
If you are searching for Australian health-research funding, see NHMRC’s own scheme pages rather than this guide; if you are searching for UK biomedical/clinical funding, MRC is the correct body.
MRC’s role within UKRI
UKRI comprises nine constituent organisations: seven research councils (AHRC, BBSRC, ESRC, EPSRC, MRC, NERC, STFC), Innovate UK, and Research England. Each council retains its own subject remit, funding schemes, and (for MRC) a distinct focus on medical and biomedical science, but all now share common UKRI-wide infrastructure: applications and award management run through the UKRI Funding Service (the successor to the older Je-S system), grant outcomes are reported annually through Researchfish, and funded-project data is published openly through Gateway to Research (GtR). Like other UKRI councils, MRC funds most standard research grants at 80% of full economic cost (fEC), calculated by the host institution using the Transparent Approach to Costing (TRAC) methodology, with the institution expected to find the remaining 20% from other resources.
What MRC funds
MRC’s portfolio spans the full translational pathway from discovery science through to applied and clinical research, including:
- Basic and discovery biomedical science (molecular biology, genetics, immunology, neuroscience, and related fields)
- Population and public health research, including epidemiology
- Clinical research and experimental medicine
- Translational research aimed at moving findings toward new diagnostics, devices, and therapeutics
- Skills, training, and career-development support for biomedical researchers
A distinctive feature of MRC’s model, alongside responsive-mode grants, is its direct funding of dedicated research institutes and units (for example the MRC Laboratory of Molecular Biology in Cambridge) rather than funding solely through university-based grant competitions — a structure that sets it apart from purely grant-awarding councils.
Main funding routes and grant types
MRC’s funding opportunities change on a rolling basis and should always be checked against the live UKRI funding finder before applying, but the recurring categories include:
Research Grants (applicant-led)
MRC’s core responsive-mode scheme for investigator-driven biomedical research. There is no fixed funding ceiling — the requested amount should be appropriate to the proposed project — and MRC funds at 80% of fEC (100% for specific exceptions), with project durations of up to five years.
Partnership Grants (applicant-led)
Funds novel collaborative partnerships between research teams working in areas of unmet biomedical need, supporting activities that build new collaborative capability, add value to existing MRC-funded research, or grow capacity in underserved research areas. Typical award size is roughly £400,000 to £2,000,000 at 100% fEC, for projects of 18 months to five years.
Translational and proof-of-concept funding
MRC runs dedicated translational schemes — for example Impact Acceleration Awards and Developmental Pathway/Proof of Concept funding — aimed at moving research toward new medicines, medical devices, diagnostics, or other interventions. Award sizes vary considerably by call (recent examples have ranged from roughly £50,000 up to multi-million-pound Proof of Concept funds); always confirm current figures and deadlines on the live opportunity listing, as these change call to call.
Fellowships, centres, and institutes
Alongside project and programme grants, MRC funds career-stage fellowships for biomedical and clinical researchers, strategic research programmes, MRC-designated centres of research excellence, and its own research institutes and units. Fellowship and studentship schemes are listed under MRC’s “People, skills and fellowships” funding category on UKRI’s site.
How MRC differs from UKRI’s other research councils
All seven UKRI research councils share the same overarching application system, fEC/TRAC costing model, and Researchfish reporting requirement, but each has a distinct subject remit:
- MRC — medical, biomedical, and clinical research
- BBSRC — biotechnology and biological sciences (non-clinical life sciences, agriculture, food)
- ESRC — economic, social, behavioural, and human data science research
- EPSRC — engineering and physical sciences
- AHRC — arts and humanities
- NERC — environmental and natural sciences
- STFC — physics, astronomy, particle physics, and large research facilities
Research that spans clinical and non-clinical life sciences, or medical and engineering questions, may be jointly funded or co-badged across MRC and a neighbouring council (for example MRC/BBSRC or MRC/EPSRC calls), reflecting UKRI’s cross-council funding model.
Where to find current MRC funding opportunities
Because deadlines, award values, and open/closed status change frequently, treat any specific figures in secondary sources (including this guide) as indicative rather than current. The authoritative, continuously updated sources are:
- UKRI funding finder (ukri.org/opportunity/) — searchable by council, filterable to MRC-led and MRC-co-funded calls
- MRC’s own council pages (ukri.org/councils/mrc/ and mrc.ukri.org) — remit, priorities, and funding category overviews
- UKRI Funding Service — where MRC applications are actually submitted and managed through to award closeout
Frequently asked questions
Is MRC the same as NHMRC?
No. MRC is the UK’s Medical Research Council, one of UKRI’s seven research councils. NHMRC is Australia’s National Health and Medical Research Council, a separate statutory agency of the Australian Government with its own schemes and grants-management system. The shared “MRC” letters are coincidental, not organisational.
What percentage of costs does MRC fund?
Like other UKRI research councils, MRC funds most standard grants at 80% of full economic cost (fEC), with the host institution expected to cover the remaining 20%; some funding types are funded at 100% fEC.
Does MRC fund only universities?
No. In addition to competitive grants to university-based researchers, MRC directly funds a network of its own research institutes and units, which is a distinctive part of its funding model compared with purely grant-awarding councils.
Where do I apply for MRC funding?
Through the UKRI Funding Service, the shared application and award-management platform used across all seven UKRI research councils.
